New England Journal of Medicine

Here is a summary of some recent studies on COVID-19.

Dua dos vaksin COVID-19 Pfizer atau AstraZeneca hampir sama berkesan dalam melawan varian Delta seperti mana ia berkesan terhadap varian Alpha.

Faced with very little data and fears that some of these patients could be particularly vulnerable to the virus, scientists are seeking to figure out how to best protect them.

A repurposed arthritis drug has shown positive results in a clinical trial of patients hospitalized with COVID-19.

Results of the study, which tested the drug in 289 hospitalized adult patients with the respiratory illness caused by the coronavirus.

While the distribution of the first vaccines for the coronavirus has raised hopes, it has also sparked some concern about side effects.

Analisis genetik pesakit COVID-19 menunjukkan bahawa jenis darah dapat mempengaruhi sama ada seseorang mengalami gejala yang lebih teruk.

Tiada seekor kucing yang terlibat menunjukkan simptom lazim seperti perbezaan suhu badan atau kehilangan berat badan.

Being overweight can raise the likelihood of being diagnosed with cancers of the stomach and digestive tract, researchers said.

Nearly half of the patients considered at high risk for recurrence might actually be low risk based on genetic factors, researchers found.

The possible falling rates of dementia cases in the United States, may offer hope that some cases of the disease might be delayed or preventable.

Vaksin denggi pertama di dunia kini dalam proses pengeluaran, dan akan berada di pasaran pada separuh kedua 2015, menurut syarikat pengeluarnya Sanofi Pasteur.